William Blair Investment Management, LLC Mirum Pharmaceuticals, Inc. Transaction History

William Blair Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$23.57 - $34.85 $1.19 Million - $1.77 Million	50,667 Added 8.08%	677,939 $23.2 Million
Q1 2024 May 08, 2024	BUY	$24.92 - $30.02 $136,910 - $164,929	5,494 Added 0.88%	627,272 $15.8 Million
Q4 2023 Feb 09, 2024	BUY	$27.14 - $34.93 $2.39 Million - $3.08 Million	88,085 Added 16.5%	621,778 $18.4 Million
Q3 2023 Nov 09, 2023	BUY	$24.63 - $32.85 $4.83 Million - $6.45 Million	196,279 Added 58.17%	533,693 $16.9 Million
Q2 2023 Aug 10, 2023	BUY	$23.51 - $30.09 $7.93 Million - $10.2 Million	337,414 New	337,414 $8.73 Million

190

54M

177K

167K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.64B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of William Blair Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on William Blair Investment Management, LLC with notifications on news.